Unilateral Sequential Sympathectomy for Palmar Hyperhidrosis (ETS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02321332|
Recruitment Status : Completed
First Posted : December 22, 2014
Last Update Posted : December 22, 2014
|Condition or disease||Intervention/treatment||Phase|
|Palmar Hyperhidrosis||Procedure: bilateral simultaneous endoscopic thoracic symapthectomy Procedure: unilateral sequential endoscopic thoracic symapthectomy.||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||400 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Unilateral Sequential Versus Bilateral Simultaneous Sympathectomy for Palmar Hyperhidrosis: a Study of 407 Cases.|
|Study Start Date :||June 2010|
|Actual Primary Completion Date :||June 2013|
|Actual Study Completion Date :||June 2013|
Active Comparator: B-ETS
Bilateral simultaneous endoscopic thoracic sympathectomy: bilateral simultaneous T2-T3 ganglionectomy.
Procedure: bilateral simultaneous endoscopic thoracic symapthectomy
Patients underwent bilateral simultaneous T2-T3 ganglionectomy using thoracoscopic approach.
Active Comparator: S-ETS
unilateral sequential endoscopic thoracic sympathectomy: unilateral T2-T3 ganglionectomy of the dominant side followed by T2-T3 ganglionectomy of the other side after 2 months interval
Procedure: unilateral sequential endoscopic thoracic symapthectomy.
Patients underwent unilateral T2-T3 ganglionectomy of the dominant side followed by T2-T3 ganglionectomy of the other side after 2 months interval.
- Number of participants developing compensatory hyperhidrosis (reflex sweating) following sympathectomy. [ Time Frame: one year ]Number pf patients developing compensatory hyperhidrosis (reflex sweating) following sympathectomy. Compensatory hyperhidrosis was graded as "severe" when the patient mentioned that sweating interfered with his or her normal activity, "moderate" when the patient indicated that his or her sweating was not bothersome and "mild" when the patient did not mention dampness or made only a brief reference.
- Number of patients who will be satisfied or unsatisfied regarding the procedure. [ Time Frame: one year ]we measure patient satisfaction regarding the procedure by asking the patients to rate their level of satisfaction as very satisfied, somewhat satisfied, somewhat dissatisfied and very dissatisfied. Patients were considered satisfied if they reported being very satisfied or somewhat satisfied.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02321332
|Study Director:||tamer youssef, MD||Mansoura Faculty of Medicine|